1. Home
  2. CFG vs RPRX Comparison

CFG vs RPRX Comparison

Compare CFG & RPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Citizens Financial Group Inc.

CFG

Citizens Financial Group Inc.

HOLD

Current Price

$63.67

Market Cap

27.4B

Sector

Finance

ML Signal

HOLD

Logo Royalty Pharma plc

RPRX

Royalty Pharma plc

HOLD

Current Price

$50.31

Market Cap

22.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CFG
RPRX
Founded
1828
1996
Country
United States
United States
Employees
17398
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.4B
22.0B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
CFG
RPRX
Price
$63.67
$50.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
18
5
Target Price
$70.17
$51.40
AVG Volume (30 Days)
4.2M
2.5M
Earning Date
04-16-2026
05-06-2026
Dividend Yield
2.86%
1.90%
EPS Growth
N/A
N/A
EPS
N/A
1.78
Revenue
N/A
$2,378,193,000.00
Revenue This Year
$20.17
$38.63
Revenue Next Year
$8.30
$4.73
P/E Ratio
$16.85
$27.84
Revenue Growth
N/A
5.06
52 Week Low
$37.93
$31.97
52 Week High
$68.79
$50.47

Technical Indicators

Market Signals
Indicator
CFG
RPRX
Relative Strength Index (RSI) 50.89 63.94
Support Level $58.09 $35.35
Resistance Level $66.37 N/A
Average True Range (ATR) 1.46 0.91
MACD -0.24 -0.03
Stochastic Oscillator 7.12 92.69

Price Performance

Historical Comparison
CFG
RPRX

About CFG Citizens Financial Group Inc.

Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through its subsidiaries, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The group's reportable business segments are: Consumer Banking and Commercial Banking. The majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services, including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management solutions, among others, through a network of branches and ATMs.

About RPRX Royalty Pharma plc

Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.

Share on Social Networks: